Why This RH Analyst Is Slashing Price Target By Almost 50%

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Why This RH Analyst Is Slashing Price Target By Almost 50%

, Benzinga - 11:56 AM ET 4/14/2025 default

RH's sales are gaining momentum and margins have inflected positive, with easy comps suggesting expansion through the first half of 2025, according to JPMorgan.

The RH Analyst: Analyst Christopher Horvers reiterated an Overweight rating, while slashing the price target from $510 to $250.

The RH Thesis: The estimates for the company have been revised after the release of fourth-quarter results and 2025 guidance, Horvers said in the note.

Check out other analyst stock ratings.

RH reported its fourth-quarter sales at $812 million and earnings at $1.58 per share, missing consensus projections of $830 million and $1.91 per share, respectively. Management guided to 2025 sales growth of 10%-13%, below consensus of 13.4%.

The analyst cut the adjusted earnings estimates for 2025 and 2026 from $13.16 to $11.28 per share and from $17.58 to $14.46 per share, respectively.

Uncertainty related to tariffs has weighed on the stock, which is now trading "at the low end of the valuation range," he further stated.

RH Price Action: Shares of RH are down 2.81% to $160 at the time of publication on Monday.

Read More:
• Trump’s 90-Day Tariff Pause Sends RH Stock Surging, Reversing Heavy Losses from Earnings Miss, Trade War Fears

Photo: Helen89 via Shutterstock